Wednesday, July 13, 2011

Dr. Reddy - Fondaprinux Sales to be constrained

The fondaparinux opportunity for Dr. Reddy is unikley to reap immediate awards because of manufacturing constraints. The production yield is low, hence Dr. Reddy sales will be constrined. About $40m annual profits from Fondaparinux opportunity would be a fair estimate.